110 related articles for article (PubMed ID: 8105302)
1. Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen.
Yasutomo K; Himeno K
Lancet; 1993 Oct; 342(8878):1062. PubMed ID: 8105302
[No Abstract] [Full Text] [Related]
2. Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen.
Salat C; Holler E; Kolb HJ; Hiller E
Lancet; 1993 Oct; 342(8878):1062. PubMed ID: 8105301
[No Abstract] [Full Text] [Related]
3. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen.
Eltumi M; Trivedi P; Hobbs JR; Portmann B; Cheeseman P; Downie C; Risteli J; Risteli L; Mowat AP
Lancet; 1993 Aug; 342(8870):518-21. PubMed ID: 8102667
[TBL] [Abstract][Full Text] [Related]
4. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation.
Schuler U; Subat S; Schmidt H; Schneider A; Ehninger G
Ann Hematol; 1996 Jul; 73(1):25-8. PubMed ID: 8695719
[TBL] [Abstract][Full Text] [Related]
6. Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Heikinheimo M; Halila R; Fasth A
Blood; 1994 May; 83(10):3036-40. PubMed ID: 8180401
[TBL] [Abstract][Full Text] [Related]
7. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.
Rio B; Bauduer F; Arrago JP; Zittoun R
Bone Marrow Transplant; 1993 Jun; 11(6):471-2. PubMed ID: 8334428
[TBL] [Abstract][Full Text] [Related]
8. Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
Bone Marrow Transplant; 2001 Mar; 27(6):635-9. PubMed ID: 11319594
[TBL] [Abstract][Full Text] [Related]
9. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Penovici M; Ledderose G; Hiller E
Leuk Lymphoma; 1999 Mar; 33(1-2):25-32. PubMed ID: 10194118
[TBL] [Abstract][Full Text] [Related]
10. Nonbacterial thrombotic endocarditis clinically mimicking veno-occlusive disease of the liver complicating autologous bone marrow transplantation.
Vukelja SJ; Baker WJ; Jeffreys P; Reeb BA; Pick T
Am J Clin Oncol; 1992 Dec; 15(6):500-2. PubMed ID: 1449113
[TBL] [Abstract][Full Text] [Related]
11. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor, angiotensin converting enzyme and endothelial cell damage in veno-occlusive disease and bone marrow transplantation.
Blann A; Collins P
Thromb Res; 1992 Jun; 66(5):617-8. PubMed ID: 1326136
[No Abstract] [Full Text] [Related]
13. [Veno-occlusive disease of the liver].
Rybicka M; Krysiak R; Okopień B
Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
[TBL] [Abstract][Full Text] [Related]
14. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
16. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
[TBL] [Abstract][Full Text] [Related]
17. High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation.
Gugliotta L; Catani L; Vianelli N; Gherlinzoni F; Miggiano MC; Bandini G; Tura S
Blood; 1994 Apr; 83(8):2385-6. PubMed ID: 8161809
[No Abstract] [Full Text] [Related]
18. Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.
Gerecitano J; Mathias C; Mick R; Duffy KM; Luger S; Stadtmauer EA; Schuster SJ; Tsai D; Nasta S; Berlin J; Phillips DK; High KA; Porter DL
J Hematother Stem Cell Res; 2003 Apr; 12(2):215-23. PubMed ID: 12804180
[TBL] [Abstract][Full Text] [Related]
19. A 32-year-old man with hepatitis C who developed progressive liver failure after a bone marrow transplant.
Lyra AC; Brunt EM; Pincus S; Di Bisceglie AM
Semin Liver Dis; 2002 Feb; 22(1):103-8. PubMed ID: 11928083
[No Abstract] [Full Text] [Related]
20. [Fulminant hepatitis-like veno-occlusive disease of the liver after allogeneic bone marrow transplantation in acute lymphoblastic leukemia].
Naito H; Arioka H; Kobayashi R; Ishikawa Y
Rinsho Ketsueki; 1993 May; 34(5):656-61. PubMed ID: 8315837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
